Patients with Duffy null status are more likely to experience misdiagnoses, unnecessary medical tests, and increased health ...
Kashiv BioSciences commercially launched Pexegra, a biosimilar referencing Neulasta, and Filra, a biosimilar referencing ...
Immuneering Corporation - Special CallCompany ParticipantsBenjamin Zeskind - Co-Founder, President, CEO & DirectorConference Call ...
A monocyte mitochondrial superoxide cutoff accurately stratified short-term survival risk in hepatocellular carcinoma.
The regulatory approval of the oral estrogen receptor antagonist is for patients whose cancer has an ESR1 mutation and has ...
The Slovak Academy of Sciences (SAV) published a long-awaited report on the composition of Covid-19 vaccines, a renowned ...
MedPage Today on MSN
Ulcerative Colitis: Next Target for CAR T-Cell Therapy?
The range of autoimmune diseases treatable with chimeric antigen receptor (CAR) T-cell therapy could be much broader than ...
(OS) observed at 9 months; standard of care benchmark is ~47% -- 53% progression-free survival (PFS) observed at 9 months; ...
US FDA approves Eli Lilly’s Inluriyo for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer: Indianapolis Saturday, September 27, 2025, 15:00 Hrs [IST] El ...
US President Donald Trump's latest round of tariffs targeting imported branded pharmaceutical products would "barely dent" the operations of major Chinese drug makers, according to analysts. The new ...
ES-SCLC accounts for the majority of small-cell lung cancer diagnoses and is characterized by rapid progression and poor ...
A team from the universities of Umeå and Ghent has discovered that neutrophils carefully control zinc levels to weaken and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback